Sponsor

·
Chinese Association of
Integrative Medicine;
China Academy of Chinese
Medicine Sciences

Editing

·
Editorial Board of
China Journal of
Orthopaedics and Traumatology

Publishing

·
Publishing House,
China Journal of
Orthopaedics and Traumatology

Overseas Distributor

·
China International Book
Trading Corporation
P.O.Box 399,Beijing,China
Code No.M587

Mail-order

·
Publishing House,
China Journal of
Orthopaedics and Traumatology
No.16A, Nanxiaojie, Dongzhimennei,
Beijing 100700,China
Tel:0086-10-84020925
Fax:0086-10-84036581
Http://www.zggszz.com
E-mail:zggszz@sina.com

骨肉瘤化疗进展

Hits: 2234 Download times: 1948 Received:April 20, 2006

作者	Author	单位	Unit	E-Mail
梁鹏	LIANG Peng	甘肃省肿瘤医院骨科,甘肃兰州730050	Department of Orthopaedics,the Cancer Hospital of Gansu,Lanzhou 730050,Gansu,China
宋建民	SONG Jian-min	甘肃省肿瘤医院骨科,甘肃兰州730050	Department of Orthopaedics,the Cancer Hospital of Gansu,Lanzhou 730050,Gansu,China

期刊信息：《中国骨伤》2007年20卷，第1期，第67-69页

DOI：doi:10.3969/j.issn.1003-0034.yyyy.nn.zzz

化疗可杀灭骨肉瘤肺部微转移灶,提高5年存活率,并为保肢提供一个安全的边界,使许多患者得以保存肢体,提高患者生存质量;化疗耐药的出现对骨肉瘤化疗提出了新挑战,但化疗在骨肉瘤治疗中的地位尚无法替代。

[关键词]:骨肉瘤抗肿瘤联合化疗方案微转移

Progression of osteosarcoma chemotherapy

Abstract:Chemotherapy can kill the micrometastasis of osteosarcoma in lung,increase the 5-year survival rate and provide a safe verge for limb salvage,thus help many patients to reserve their limb and improve their quality of life.The chemotherapy-resistant give a new challenge for treating osteosarcoma,but nothing can substitute chemotherapy in treating osteosarcoma.

KEYWORDS:Osteosarcoma Antineoplastic combined chemotherapy protocols Micrometastasis

引用本文，请按以下格式著录参考文献：

中文格式:	梁鹏,宋建民.骨肉瘤化疗进展[J].中国骨伤,2007,20(1):67~69
英文格式:	LIANG Peng,SONG Jian-min.Progression of osteosarcoma chemotherapy[J].zhongguo gu shang / China J Orthop Trauma ,2007,20(1):67~69

View Full Text View/Add Comment Download reader